Vaccine Injury Blindspot, Ryan Richardson, RNC Store, Laetrile/B17, Food System Changes, Franciscea Rheumatic Relief, Pfizer Failed Flu Data, Darrlene Alquiza, Informed Policy Advocates, California Rights, Ancient Mummy Sourdough, George Washington’s Beer and MORE!

June 5, 2026 3-5pm ET

Friday on The Robert Scott Bell Show:

Hour 1

Pediatricians Receive Little Training on Vaccine Injuries, Doctors Report Medical school students and pediatric residents receive little, if any, training on vaccines, vaccine-related adverse events, and how to identify or treat vaccine injuries, with curricula instead focusing primarily on the vaccine schedule, the benefits of vaccination, and strategies for addressing vaccine hesitancy, according to multiple physicians and experts who spoke with The Defender. Florida pediatrician Dr. Brian Thornburg stated that pediatricians get zero training in identifying vaccine injuries and that medical board exams require knowledge of the schedule but contain no questions about potential complications or injuries. Texas pediatrician Dr. Osvaldo Villarreal noted that vaccine injuries are not recognized or discussed in medical schools, while Dr. Joseph Varon of the Independent Medical Alliance said training covers common reactions like fever or injection-site issues but offers little practical experience with uncommon, delayed, or complex presentations. A 2023 study in AJPM Focus found that 79% of first- and second-year medical students reported insufficient coverage of vaccine topics, with many calling for expanded education on policy, development, testing, and risks. Dr. Larry Palevsky and Dr. Kimberly Biss described similar experiences of minimal or no instruction on injuries or ingredients during their training, and Dr. Jane Orient highlighted the absence of education on reporting systems like VAERS or the statute of limitations for compensation claims. Experts noted that any discussion of risks is often framed as rare and controversial, with emphasis overwhelmingly on benefits, leaving physicians unprepared to evaluate patients who develop new symptoms post-vaccination. The pattern reflects a broader tendency in medical education to present vaccines as an unqualified success story, potentially contributing to under-recognition of injuries and challenges in addressing parental concerns or seeking non-pharmaceutical approaches.

Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!

Today’s Homeopathic Hit is Franciscea Uniflora, commonly known as Manaca.

Boericke highlights this remedy for chronic stiffness of the muscles, gonorrhoeal rheumatism, syphilitic and rheumatic states, heat over the body, aching that is better from sweat, spinal and occipital pains, pericarditis with rheumatism, and urine containing uric acid.

Download the  Information Sheet

Hour 2

Major Journal Under Fire for Omitting Pfizer’s Failed Flu Data in Seniors A leading medical journal is facing sharp criticism for publishing a review on influenza vaccines in older adults that omitted or downplayed data from a large Pfizer trial showing the company’s candidate failed to meet key efficacy endpoints in seniors, raising fresh concerns about selective reporting, industry influence, and the reliability of published medical literature used to shape public health policy. The review, which presented an overall positive picture of flu vaccination benefits in the elderly, did not adequately address the Pfizer study’s negative results on clinical outcomes such as reduced hospitalizations or deaths, despite the trial’s size and relevance, prompting accusations that the journal prioritized narrative consistency over comprehensive evidence. Critics argue this omission distorts the risk-benefit assessment for seniors, a population with high flu vaccination rates but questionable evidence of meaningful protection, and contributes to ongoing overconfidence in annual flu shots despite historically modest and variable effectiveness. The episode fits a broader pattern of publication bias where negative or inconvenient trial results are minimized, buried in supplements, or excluded from high-impact summaries, eroding trust in the scientific process at a time when public skepticism toward pharmaceutical products and regulatory bodies remains elevated. Brownstone Institute and independent analysts highlighted the discrepancy as emblematic of deeper problems in peer review, conflicts of interest, and the tendency of prestigious journals to protect institutional narratives rather than rigorously interrogate data, especially when they challenge routine recommendations. The controversy underscores calls for greater transparency, mandatory registration and reporting of all trial outcomes, and independent re-analysis of flu vaccine data in high-risk groups, particularly as the Make America Healthy Again movement pushes for root-cause approaches to respiratory illness and reduced reliance on annual vaccinations with limited long-term evidence. Defenders of the journal maintain that space constraints and editorial discretion guide inclusion decisions, but critics counter that selective omission of a major manufacturer’s failed trial in the target population constitutes scientific malpractice with real-world consequences for informed consent and public health policy. The incident adds to mounting scrutiny of how medical journals handle pharmaceutical-sponsored research and whether current practices serve patients or perpetuate a cycle of overstated benefits and underreported limitations.

FDA Allows Public Comments on Moderna’s mRNA Flu Vaccine Application The FDA has opened a public comment period on Moderna’s application for its mRNA-based seasonal influenza vaccine, giving Americans an opportunity to submit feedback on the experimental product before any potential approval or recommendation for widespread use, amid ongoing concerns about mRNA platform safety, lipid nanoparticle distribution, spike protein persistence, and the limited long-term data for annual flu shots that have historically shown modest and highly variable effectiveness. The comment window follows Moderna’s submission of clinical trial data for the mRNA flu candidate, which uses the same technology platform as its COVID-19 shots, raising questions about whether the agency will apply rigorous scrutiny or fast-track the product under pressure to expand mRNA applications beyond COVID. Critics within the health freedom community argue that public input is essential given the history of rushed mRNA authorizations, inadequate placebo-controlled safety studies for the full childhood and adult schedules, and emerging signals of immune imprinting, IgG4 class switching, and other unintended effects observed with repeated dosing of similar products. Supporters of the technology maintain that mRNA allows rapid adaptation to circulating flu strains and could improve upon traditional egg-based or cell-based flu vaccines that often mismatch dominant variants. The FDA’s move comes as the agency faces internal turnover, leadership changes, and broader MAHA-driven scrutiny of pharmaceutical influence, accelerated approval pathways, and the need for transparent risk-benefit analysis, particularly for annual products administered to healthy populations including children and pregnant women. Jon Fleetwood notes that the comment period provides a rare formal channel for concerned citizens, physicians, and scientists to highlight potential risks, demand longer follow-up data, and question the wisdom of adding another mRNA product to an already crowded schedule without addressing cumulative effects or true informed consent. The development underscores ongoing debates over the expansion of mRNA technology into routine vaccines while public trust in regulatory processes remains low following the COVID-19 era. Comments can be submitted through the official docket, with the period offering a limited window for public participation before final regulatory decisions are made.

Informed Policy Advocates:

In 2019, the founders first met fighting a bill that would breed discrimination and deny children access to school. They with a few others created a 501(c)(3), Protection of the Educational Rights of Kids (PERK), which successfully fought against restrictive medical mandates and protected the rights of parents, children, educators, and essential workers. The founders achieved significant victories by halting detrimental bills in the legislature, while building relationships with state representatives and key leaders in Sacramento.

After five years of successful advocacy wins, Darrlene, Jessica, and Kris recognized that California’s constantly evolving policy landscape required a more focused and targeted approach. This insight led to moving on from PERK and the creation of Informed Policy Advocates (IPA), a 501(c)(4) organization dedicated to reforming California’s medical mandate policies and advocating for stronger consumer protections and civil rights. IPA’s mission is to drive long-term, sustainable change within California’s legislative framework, ensuring the health and safety of its residents while protecting civil and consumer rights.

Ötzi the Iceman’s 5,300-Year-Old Yeast Used to Bake Sourdough Bread Scientists have successfully revived yeast extracted from the 5,300-year-old stomach contents of Ötzi the Iceman, the naturally mummified Neolithic man discovered in the Italian Alps in 1991, and used it to bake loaves of sourdough bread that carry the distinctive microbial signature of Copper Age European fermentation, offering a rare direct taste of prehistoric cuisine and new insights into ancient human microbiomes. Researchers from the Eurac Research Institute in Bolzano, Italy, carefully isolated viable yeast cells from Ötzi’s preserved intestinal contents, which contained remnants of his final meal including ibex meat, grains, and traces of the yeast that helped ferment his food. After culturing the ancient strain, they combined it with modern flour and water to create a sourdough starter that produced bread with a complex, earthy flavor profile distinct from contemporary commercial yeasts, confirming the continuity of certain wild yeast lineages over millennia. The project not only demonstrates the remarkable resilience of some microorganisms but also provides a tangible connection to Ötzi’s daily life, showing that his community practiced fermentation techniques similar to those still used in traditional sourdough baking today. Genetic analysis revealed the yeast belongs to a lineage related to strains found in modern European sourdough and beer production, suggesting long-term human-yeast co-evolution tied to agriculture and food preservation. The bread was baked and sampled by researchers and presented as a symbolic reconstruction of Neolithic foodways, highlighting how ancient people leveraged naturally occurring microbes for nutrition and flavor long before the invention of commercial baking yeast. The study adds to the growing body of research on ancient microbiomes and paleodiet, illustrating how preserved human remains continue to reveal details about prehistoric health, diet, and food technology that written records cannot capture. Experts noted the success of reviving the yeast underscores the potential for further archaeological microbiology projects that could illuminate historical food practices, microbial diversity, and even clues to modern gut health by comparing ancient and contemporary microbial communities.

New York Public Library Helps Bring George Washington’s Beer Recipe Back to Life to Celebrate America 250 The New York Public Library has partnered with brewers and historians to recreate George Washington’s original 18th-century beer recipe using period-appropriate ingredients and techniques, producing a batch of the historic ale as part of nationwide celebrations leading up to America’s 250th anniversary in 2026. Washington, an avid brewer at Mount Vernon who kept detailed notes on his small-scale production, documented a recipe that called for a mix of barley, hops, and other grains to create a strong, nourishing beverage suitable for his household, workers, and guests, reflecting the self-sufficient farming practices common among colonial planters. The library’s team accessed Washington’s original papers and correspondence to ensure historical accuracy, working with craft brewers who adapted the recipe for modern small-batch production while preserving the spirit and flavor profile of the colonial-era beer, which was likely robust, somewhat cloudy, and higher in alcohol content than many contemporary lagers. The project highlights Washington’s role not only as a military and political leader but also as a practical farmer and entrepreneur who experimented with various crops and brewing methods to sustain his estate. Tastings and educational events are planned around the recreated beer to engage the public with early American foodways, self-reliance, and the cultural importance of brewing in the founding era, when beer and cider were safer to drink than water in many communities. The initiative is part of broader America 250 programming that seeks to connect modern Americans with the daily lives and innovations of the Revolutionary period, showcasing how figures like Washington balanced leadership with hands-on agricultural management. Historians note that Washington’s beer was likely consumed regularly at Mount Vernon and shared with visitors, embodying the resourcefulness and hospitality of the time. The recreation effort underscores growing public interest in historical food and drink as living history, with the New York Public Library using its vast archival collections to make primary sources accessible and relevant for contemporary audiences. The beer is expected to be featured at select events and possibly made available in limited releases through partner breweries as part of the lead-up to the 2026 semiquincentennial celebrations.

Remember Friends, The Power to Heal is Yours!